128 related articles for article (PubMed ID: 36175378)
1. Auer rods and faggot cells: A review of the history, significance and mimics of two morphological curiosities of enduring relevance.
Sehgal T; Sharma P
Eur J Haematol; 2023 Jan; 110(1):14-23. PubMed ID: 36175378
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83.
Ritter J; Vormoor J; Creutzig U; Schellong G
Med Pediatr Oncol; 1989; 17(3):202-9. PubMed ID: 2546027
[TBL] [Abstract][Full Text] [Related]
3. The contribution of Auer rods to the classification and prognosis of myelodysplastic syndromes.
Seymour JF; Estey EH
Leuk Lymphoma; 1995 Mar; 17(1-2):79-85. PubMed ID: 7773165
[TBL] [Abstract][Full Text] [Related]
4. Auer rods and myeloperoxidase: an approach for investigating changes at the molecular level in acute myeloid leukaemia (AML).
Pearson EC
Med Hypotheses; 1989 Nov; 30(3):175-7. PubMed ID: 2557530
[TBL] [Abstract][Full Text] [Related]
5. John Auer and Auer rods; controversies revisited.
Yoshida Y; Oguma S; Ohno H
Leuk Res; 2009 May; 33(5):614-6. PubMed ID: 18947869
[TBL] [Abstract][Full Text] [Related]
6. [Auer rods as tumor markers].
Jehn U
Internist (Berl); 1990 Feb; 31(2):163. PubMed ID: 2156783
[No Abstract] [Full Text] [Related]
7. Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.
Strupp C; Gattermann N; Giagounidis A; Aul C; Hildebrandt B; Haas R; Germing U
Leuk Res; 2003 May; 27(5):397-404. PubMed ID: 12620291
[TBL] [Abstract][Full Text] [Related]
8. [Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].
Vormoor J; Ritter J; Creutzig U; Schellong G
Klin Padiatr; 1989; 201(4):227-32. PubMed ID: 2674529
[TBL] [Abstract][Full Text] [Related]
9. Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases.
Willis MS; McKenna RW; Peterson LC; Coad JE; Kroft SH
Am J Clin Pathol; 2005 Aug; 124(2):191-8. PubMed ID: 16040288
[TBL] [Abstract][Full Text] [Related]
10. Chromosomes, Auer rods and prognosis in acute myeloid leukaemia.
Billström R; Nilsson PG; Mitelman F
Eur J Haematol; 1988 Mar; 40(3):273-8. PubMed ID: 2833409
[TBL] [Abstract][Full Text] [Related]
11. Morphological classification, response to therapy, and survival in 263 adult patients with acute nonlymphoblastic leukemia.
Mertelsmann R; Tzvi Thaler H; To L; Gee TS; McKenzie S; Schauer P; Friedman A; Arlin Z; Cirrincione C; Clarkson B
Blood; 1980 Nov; 56(5):773-81. PubMed ID: 6932977
[TBL] [Abstract][Full Text] [Related]
12. Significance of Phi bodies in acute leukaemia.
Cardullo Lde S; Morilla R; Catovsky D
J Clin Pathol; 1981 Feb; 34(2):153-7. PubMed ID: 6262384
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of auer rods in myelodysplasia.
Seymour JF; Estey EH
Br J Haematol; 1993 Sep; 85(1):67-76. PubMed ID: 8251411
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Auer rods in acute myeloblastic leukaemia (AMyL).
Pearson EC
J Clin Pathol; 1986 May; 39(5):569-72. PubMed ID: 3013944
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
16. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.
Zhou Y; Moon A; Hoyle E; Fromm JR; Chen X; Soma L; Salipante SJ; Wood BL; Wu D
Cytometry B Clin Cytom; 2019 Jan; 96(1):67-72. PubMed ID: 30417521
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
Zhou X; Mei C; Zhang J; Lu Y; Lan J; Lin S; Zhang Y; Kuang Y; Ren Y; Ma L; Wei J; Ye L; Xu W; Li K; Lu C; Jin J; Tong H
Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434
[TBL] [Abstract][Full Text] [Related]
18. Mutational features of myelodysplastic syndromes with Auer rods reveal them are more akin to acute myeloid leukemia.
Huang H; Qin T; Xu Z; Shi Z; Li B; Pan L; Hu N; Qu S; Huang G; Gale RP; Xiao Z
Br J Haematol; 2020 Mar; 188(5):796-800. PubMed ID: 31880320
[No Abstract] [Full Text] [Related]
19. ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
Prats-Martín C; Burillo-Sanz S; Morales-Camacho RM; Pérez-López O; Suito M; Vargas MT; Caballero-Velázquez T; Carrillo-Cruz E; González J; Bernal R; Pérez-Simón JA
Cancer Med; 2020 Jun; 9(11):3637-3646. PubMed ID: 32216059
[TBL] [Abstract][Full Text] [Related]
20. AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial.
Hoyle CF; de Bastos M; Wheatley K; Sherrington PD; Fischer PJ; Rees JK; Gray R; Hayhoe FG
Br J Haematol; 1989 May; 72(1):45-53. PubMed ID: 2736242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
